Ingevity Q1 sales rise driven by Performance Materials segment growth

Ingevity

06/05/2026 22:15

Overview

US specialty materials firm's Q1 sales rose 4%, beating analyst expectations

Adjusted EPS for Q1 rose to $1.15 from $1.01 a year ago

Company completed two divestitures and reaffirmed full-year guidance

Outlook

Ingevity reaffirms 2026 net sales guidance of $1.05 bln to $1.15 bln

Company expects 2026 adjusted EBITDA of $370 mln to $395 mln

Ingevity sees 2026 adjusted EPS of $4.70 to $5.20

Result Drivers

PRICING AND MIX - Performance Materials sales rose on annual pricing actions, favorable mix, and higher volume

COMPETITIVE PRESSURE - Performance Chemicals' Road Markings sales declined 10% as competitive pressure reduced volumes

Company press release: ID:nBw4FVyWHa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Beat
$258 mln
$254.73 mln (3 Analysts)
Q1 EPS
$1.66
Q1 Net Income
$59.80 mln
Q1 Gross Profit
$116.40 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the diversified chemicals peer group is "buy"

Wall Street's median 12-month price target for Ingevity Corp is $80.00, about 3.8% above its May 5 closing price of $77.10

The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 14 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)